---
search:
  boost: 3
---

# Gout

This is a subcategory of Analgesic Agents.

## Formulary

### Preferred

| Preferred                             | Generic Name                    | Quantity                  | Time (Days)               |
|---------------------------------------|---------------------------------|---------------------------|---------------------------|
| Allopurinol 100, 300 MG <sup>QL</sup> | Allopurinol Tab (all strengths) | 204                       | 102                       |
| Colchicine Tab <sup>PA QL</sup>       | Colchicine Tab (all strengths)  | Determined pursuant to PA | Determined pursuant to PA |
| Colcrys Tab <sup>PA QL</sup>              | Colchicine Tab (all strengths)  | Determined pursuant to PA | Determined pursuant to PA |
| Probenecid <sup>QL</sup>              | Probenecid Tab (all strengths)  | 408                       | 102                       |

### Non-Preferred

| Non-Preferred                       | Generic Name                                 | Quantity                  | Time (Days)               |
|-------------------------------------|----------------------------------------------|---------------------------|---------------------------|
| Allopurinol 200 MG <sup>QL</sup>    | Allopurinol Tab (all strengths)              | 204                       | 102                       |                                    |                           |
| Mitigare <sup>BvG QL</sup>          | Colchicine Cap (all strengths)               | Determined pursuant to PA | Determined pursuant to PA |
| Febuxostat                          |                                              |                           |                           |
| Gloperba Susp <sup>QL</sup>         | Colchicine Soln (all strengths)              | Determined pursuant to PA | Determined pursuant to PA |
| Probenecid/Colchicine <sup>QL</sup> | Probenecid w/ Colchicine Tab (all strengths) | Determined pursuant to PA | Determined pursuant to PA |

## Authorizations

**Length of Authorizations** : 365 days except 180 days for Familial Mediterranean Fever

**All Authorizations** : Must be prescribed in accordance with FDA approved labeling

## Criteria

### Clinical PA

Clinical PA Criteria

-   Must have had an inadequate clinical response with an NSAID and oral corticosteroid within the last 30 days for acute gout diagnosis **OR**
-   Must have had an inadequate clinical response of at least **30 days** with the maximally tolerated xanthine oxidase inhibitor dose for chronic gout diagnosis

### Non-Preferred

Non-Preferred Criteria

-   Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred drug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    -   For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage formulation
-   Must have had an inadequate clinical response of at least **30 days** with at least **one preferred** drug
    -   For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    -   For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

### Colchicine Capsule (Mitigare)

Additional Colchicine Capsule (Mitigare) Criteria

-   Must have had an inadequate clinical response of **30 days** with colchicine tablets

### Colchicine Solution (Gloperba)

Additional Colchicine Solution (Gloperba) Criteria

-   Must be unable to swallow tablets or capsules for authorization of colchicine solution

### Subsequent Authorization

Subsequent Authorization Criteria

-   Must provide documentation of patient’s clinical response to treatment and ongoing safety monitoring

**QL** – All colchicine products: 6 doses per claim for acute gout; 2 doses per day for 30 days for chronic gout; 4 doses per day per 30 days for Familial Mediterranean Fever

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230401_UPDL_Criteria%20_APPROVED.pdf#page=8){ :target="_blank" rel="noopener"}


[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230401_UPDL_v7_Approved.pdf#page=8){ :target="_blank" rel="noopener"}

[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf#overlay-context=drug-coverage){ :target="_blank" rel="noopener"}
